Streetbeat News

Products Services

ASML

META

NVDA

SOXL

SOXS

TSM

XLK

On April 17, U.S. stock indexes experienced fluctuations amid concerns over rising interest rates and corporate earnings reports. The S&P 500, Dow Jones, and Nasdaq saw varied losses, with tech stocks, particularly Nvidia and Meta Platforms, leading declines. Nvidia-focused ETFs and semiconductor stocks were in the spotlight, with significant movements in both bullish and bearish ETFs related to Nvidia and the semiconductor industry.

Portfolio Pulse from Surbhi Jain

April 18, 2024 | 12:45 pm

ALSN

Allison Transmission has partnered with HST Otomotiv to deliver the X1100-5A4 cross-drive transmission for the Next Generation T-155 Firtina Howitzer for the Turkish Armed Forces, expecting to drive $100M of incremental annual revenue in its Defense end market. The initial delivery includes 10 transmissions, with full production scheduled for July 2024, aiming to deliver a total of 140 Firtina Howitzers. The X1100 Series transmission is designed for heavy tracked combat vehicles, offering enhanced maneuverability, fuel efficiency, and low maintenance.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:45 pm

LUCY

Innovative Eyewear, Inc. has announced the signing of UK football legend Micah Richards as an official brand ambassador for its ChatGPT smart eyewear under the Lucyd, Nautica, Eddie Bauer, and Reebok brands. Richards, a former England International footballer and successful broadcaster, is expected to help the company reach new athletes and sports fans, increasing brand awareness.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:44 pm

AMPX

Amprius Technologies, Inc. has announced receiving multiple purchase orders from AALTO for its SiMaxx 450 Wh/kg high-energy cells, indicating a strong demand for its advanced battery technology.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:43 pm

ACHR

Archer Aviation Inc. (NYSE:ACHR) has announced strategic hires and the opening of a new office in Washington D.C. to bolster its government relations efforts as it prepares for the commercial launch of its electric vertical takeoff and landing (eVTOL) aircraft. The team, led by former FAA Chief Billy Nolen, includes key policy and regulatory affairs leaders. The new office is located near FAA and DOT headquarters and will showcase Archer's eVTOL technology to policymakers. This move is part of Archer's proactive approach to efficiently progress through the U.S. regulatory process.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:38 pm

MBRX

The European Medicines Agency has granted Orphan Drug Designation to Moleculin's treatment for Acute Myeloid Leukemia, potentially accelerating its development and approval process in Europe.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:36 pm

NRXP

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has regained compliance with Nasdaq's bid price requirement, ensuring its continued listing. The company anticipates reaching four key milestones, including data releases from trials in Suicidal Bipolar Depression and Chronic Pain, an NDA filing for IV Ketamine, and a distribution of HOPE Therapeutics shares to shareholders. Recent advancements in ketamine formulations and potential treatments for UTI/pyelonephritis could significantly enhance shareholder value.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:36 pm

BNTC

BPTH

THCH

Bio-Path Holdings (BPTH) shares surged after announcing the completion of its second dose cohort in a Phase 1/1b clinical trial of BP1002 for treating acute myeloid leukemia. TH International (THCH) shares rose following a report of increased Q4 financial results year-over-year. Benitec Biopharma (BNTC) shares increased after announcing a $40 million oversubscribed private placement financing and positive interim clinical data for BB-301 in a Phase 1b/2a study.

Portfolio Pulse from ryanfaloona@benzinga.com

April 18, 2024 | 12:35 pm

NRSN

NeuroSense presented data at the American Academy of Neurology Annual Meeting, validating the Phase 2b topline readout. The presentation, given by Merit Cudkowicz of Massachusetts General, highlighted positive clinical effects and a trend toward impact on Neurofilament biomarker levels.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:34 pm

DRIO

DarioHealth Corp. (NASDAQ:DRIO) has announced two new contracts to provide integrated chronic condition management solutions, focusing on cardiometabolic health, to a national supply chain company and a regional education organization starting in Q2 2024. The solutions include support for diabetes, pre-diabetes, hypertension, weight management, and GLP-1 medication management, leveraging Dario's technology and data insights for personalized care.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:34 pm